Behavioral Pharmacology Research Unit; Johns Hopkins Bayview Campus
Baltimore, Maryland, 21224, United States
NCT Number: NCT00344812
A 17 week, double-blind, randomized, parallel group, four arm design outpatient study comparing LAAM, buprenorphine and two dose levels of methadone for the treatment of opioid dependence.
Looking for future studies?
Notify Me21 year–55 year
All sexes
Interventional
Phase 2
Baltimore, Maryland, 21224, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion
Exclusion
Johns Hopkins University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04325659
Chemically-Induced Disorders, Mental Disorders
Baltimore, Maryland, United States
View Trial DetailsNCT03969238
Agnosia, Chemically-Induced Disorders
Charlottesville, Virginia, United States
View Trial DetailsNCT04454645
Chemically-Induced Disorders, Infant Development
Newark, Delaware, United States
View Trial DetailsNCT03089983
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Kajang, Selangor, Malaysia
View Trial Details